Jeffrey Eisele
Corporate Officer/Principal at APELLIS PHARMACEUTICALS, INC.
Net worth: 2 M $ as of 31/05/2024
Profile
Jeffrey Eisele is currently working as the Chief Development Officer at Apellis Pharmaceuticals, Inc. since 2022.
Previously, he worked at Novartis, Inc. as the VP-Global Biostatistics & Head-Neuroscience.
Dr. Eisele completed his graduate and doctorate degrees at the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/01/2024 | 57,208 ( 0.05% ) | 2 M $ | 31/05/2024 |
Jeffrey Eisele active positions
| Companies | Position | Start |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2020 |
Former positions of Jeffrey Eisele
| Companies | Position | End |
|---|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Corporate Officer/Principal | - |
Training of Jeffrey Eisele
| George Washington University | Undergraduate Degree |
| University of Michigan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Eisele
